EMRIS Pharma vs OncoDecipher
EMRIS Pharma vs OncoDecipher, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EMRIS Pharma is on 45/100 and OncoDecipher on 43/100.
At a glance
| Measure | EMRIS Pharma | OncoDecipher |
|---|---|---|
| What it is | Developing topical treatments to prevent and treat skin toxicities from cancer therapies. | OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability. |
| Category | Life Sciences, Oncology, Biotech, MedTech | Life Sciences, Cancer, Oncology, Mutation |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2021 | 2015 |
| Headquarters | Tel Aviv, Israel | Cambridge, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | EMRIS Pharma | OncoDecipher |
|---|---|---|
| Employees | 7 | Not published |
| Total funding | Not published | $1.0M |
| Latest round | Not published | Seed |
| LinkedIn followers | 2,441 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EMRIS Pharma | OncoDecipher |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 45/100 | 43/100 |
| Traction | 9/100 | 30/100 |
| Team | 60/100 | 60/100 |
| Search visibility | 34/100 | 3/100 |
| Quality | 58/100 | 52/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (30/100) | Not published |
| Domain ratingLink authority, 0-100 | 10/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EMRIS Pharma | OncoDecipher |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
EMRIS Pharma vs OncoDecipher: common questions
Which is better, EMRIS Pharma or OncoDecipher?
On our 0-100 score EMRIS Pharma rates higher (45/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
Read the full EMRIS Pharma review and pricing or the OncoDecipher review and pricing. You can also browse other EMRIS Pharma alternatives we track.